INSYS Therapeutics and University of California (UC) San Diego Center for Medicinal Cannabis Research to Collaborate on Clinical Trial
Company’s pharmaceutical-grade cannabidiol (CBD) oral solution will be evaluated by UC San Diego/CMCR researchers as potential treatment for symptoms of autism
This could be huge but the diagnosis of autism is generally wildly exaggerated by the inclusion of the so-called autism spectra, primarily Asperger Syndrome.
Without intentionally meaning to minimize the great difficulty faced by Asperger victims, the problems generally are quite different - most acutely in language development.
Modern mythologists deny the plain facts of Albert Einstein's struggles with autism that Einstein never did himself. A fellow Princeton physics professor's misleading contemporaneous tome is used as a bible for the deniers that do not want to admit the truth of Einstein's learning disability.
Another autistic professor, who never "came out" of her autism, [both very extraordinary people] even claims autism provided the very basis of a vision impossible for ordinary folk though Temple Grandin's "visual learners" reached far beyond even the wildly expanded autism spectra.
I so wish the remaining fanatical deniers of medical benefits of cannabinoids could be deprived of their powers to destroy that keeps INSY endangered.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.